$2.95
0.67% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US7599101026
Symbol
KRMD

Repro-Med Systems, Inc. Target price 2025 - Analyst rating & recommendation

Repro-Med Systems, Inc. Classifications & Recommendation:

Buy
80%
Hold
20%

Repro-Med Systems, Inc. Price Target

Target Price $5.50
Price $2.95
Potential
Number of Estimates 5
5 Analysts have issued a price target Repro-Med Systems, Inc. 2026 . The average Repro-Med Systems, Inc. target price is $5.50. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 5 analysts: 4 Analysts recommend Repro-Med Systems, Inc. to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Repro-Med Systems, Inc. stock has an average upside potential 2026 of . Most analysts recommend the Repro-Med Systems, Inc. stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 33.65 38.98
17.99% 15.84%
EBITDA Margin -16.52% -3.60%
49.87% 78.21%
Net Margin -17.83% -11.60%
63.27% 34.92%

5 Analysts have issued a sales forecast Repro-Med Systems, Inc. 2025 . The average Repro-Med Systems, Inc. sales estimate is

$39.0m
Unlock
. This is
11.12% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$39.3m 12.07%
Unlock
, the lowest is
$38.5m 9.75%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $33.7m 17.99%
2025
$39.0m 15.84%
Unlock
2026
$44.7m 14.60%
Unlock
2027
$53.3m 19.25%
Unlock

5 Analysts have issued an Repro-Med Systems, Inc. EBITDA forecast 2025. The average Repro-Med Systems, Inc. EBITDA estimate is

$-1.4m
Unlock
. This is
71.16% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-360k 92.59%
Unlock
, the lowest is
$-3.5m 27.98%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-5.6m 40.85%
2025
$-1.4m 74.79%
Unlock
2026
$1.6m 214.43%
Unlock
2027
$5.4m 234.46%
Unlock

EBITDA Margin

2024 -16.52% 49.87%
2025
-3.60% 78.21%
Unlock
2026
3.59% 199.72%
Unlock
2027
10.07% 180.50%
Unlock

5 Repro-Med Systems, Inc. Analysts have issued a net profit forecast 2025. The average Repro-Med Systems, Inc. net profit estimate is

$-4.5m
Unlock
. This is
18.36% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-4.2m 25.05%
Unlock
, the lowest is
$-4.6m 16.74%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-6.0m 56.67%
2025
$-4.5m 24.64%
Unlock
2026
$-1.8m 61.28%
Unlock
2027
$460k 126.29%
Unlock

Net Margin

2024 -17.83% 63.27%
2025
-11.60% 34.92%
Unlock
2026
-3.92% 66.21%
Unlock
2027
0.87% 122.19%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -0.13 -0.10
56.67% 23.08%
P/E negative
EV/Sales 3.36

5 Analysts have issued a Repro-Med Systems, Inc. forecast for earnings per share. The average Repro-Med Systems, Inc. EPS is

$-0.10
Unlock
. This is
16.67% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.09 25.00%
Unlock
, the lowest is
$-0.10 16.67%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.13 56.67%
2025
$-0.10 23.08%
Unlock
2026
$-0.04 60.00%
Unlock
2027
$0.01 125.00%
Unlock

P/E ratio

Current -25.56 225.61%
2025
-30.10 17.76%
Unlock
2026
-77.63 157.91%
Unlock
2027
295.00 480.01%
Unlock

Based on analysts' sales estimates for 2025, the Repro-Med Systems, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.74 12.31%
2025
3.36 10.06%
Unlock
2026
2.94 12.74%
Unlock
2027
2.46 16.14%
Unlock

P/S ratio

Current 3.88 9.04%
2025
3.49 10.00%
Unlock
2026
3.05 12.74%
Unlock
2027
2.56 16.14%
Unlock

Current Repro-Med Systems, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Piper Sandler
Locked
Locked
Locked May 08 2025
Piper Sandler
Locked
Locked
Locked Feb 14 2025
Craig-Hallum
Locked
Locked
Locked Jan 17 2025
Lake Street
Locked
Locked
Locked Jan 14 2025
Canaccord Genuity
Locked
Locked
Locked Nov 14 2024
Craig-Hallum
Locked
Locked
Locked Nov 14 2024
Piper Sandler
Locked
Locked
Locked Nov 14 2024
Analyst Rating Date
Locked
Piper Sandler:
Locked
Locked
May 08 2025
Locked
Piper Sandler:
Locked
Locked
Feb 14 2025
Locked
Craig-Hallum:
Locked
Locked
Jan 17 2025
Locked
Lake Street:
Locked
Locked
Jan 14 2025
Locked
Canaccord Genuity:
Locked
Locked
Nov 14 2024
Locked
Craig-Hallum:
Locked
Locked
Nov 14 2024
Locked
Piper Sandler:
Locked
Locked
Nov 14 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today